share_log

佰仁医疗(688198.SH):介入肺动脉瓣及输送系统进入创新医疗器械特别审查程序

Beijing Balance Medical Technology Co., Ltd. (688198.SH): The pulmonary artery valve and delivery system have entered the special review process for Innovative Medical Management.

Gelonghui Finance ·  Jan 3 03:19

On January 3, Glorious Exchange reported that Beijing Balance Medical Technology Co., Ltd. (688198.SH) announced that its independently developed first all-comer interventional pulmonary valve and delivery system has been approved by the National Medical Products Administration's Medical Device Technology Evaluation Center, entering the special review process for Innovative Medical Management medical instruments. The interventional pulmonary valve and delivery system is specifically designed for patients with complex congenital heart disease who require catheter-based artificial biological pulmonary valve replacement after surgical repair and reconstruction of the right ventricular outflow tract. This product is the third interventional valve product from the company to enter the special review process for Innovative Medical Management medical instruments and is an important part of the series of products for the full lifecycle management of pulmonary valve patients.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment